PharmiWeb.com - Global Pharma News & Resources
03-Apr-2020

FMI Revises Zika Virus Testing Market Forecast, as COVID-19 Pandemic Continues to Expand Quickly

VALLEY COTTAGE, N.Y. – The recent outbreak of Zika in Brazil and in the rest of Latin America, the Caribbean, the United States, Canada and various parts of Europe was caused by a more virulent viral strain from Asia. This has increased the rate of Zika virus tests being conducted worldwide. A new research report by Future Market Insights highlights the current as well as future scenario of the Zika virus testing market. This report titled ‘Zika Virus Point-of-Care Testing Market: Global Industry Analysis and Opportunity Assessment 2016 – 2020’ presents a forecast of the Zika virus testing market for the said period. The market has been analyzed on the basis of factors driving the demand for testing products, trends that are prevalent in the global market and also the restraints that may hinder market revenue growth. According to the report, the global Zika virus testing market registered a market value of over US$ 4,100 Mn in 2017, which is expected to reach over US$ 4,400 Mn by the end of 2020.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2913

Carribean Region to Dominate the Zika Virus POC Testing Market with a High Growth Rate

Point-of-Care testing including the Rapid ELISA Test and Rapid IgG/IgM Zika Virus Test have emerged as powerful diagnostic tools for screening Zika virus infections. Manufacturers are offering sophisticated diagnostic kits that help in early diagnosis of Zika virus and provide results in about 15–20 minutes or an hour. Some of the most prominent Zika prone countries experiencing contraction or very slight growth in the Zika virus POC testing market are Brazil, Puerto Rico and United States. This is due to the fact that probable cases for Zika dropped by more than 70% during the one year period ending in 2017. Yet countries like United States are extra conscious about the spread of Zika virus in the region.

Request for covid19 Impact Analysis: https://www.futuremarketinsights.com/covid19/rep-gb-5924

There have been many travel related cases, in which travelling from a disease free country to a place with a high prevalence of Zika infects the region. Thus, the POC testing market is not expected to take a halt any time soon. Among the major regions of the global market, Latin America is expected to lead with revenue in excess of US$ 2,400 Mn by the end of 2017. The Carribean region is anticipated to project the highest growth rate during the forecast period 2017-2020.

Leading Players Operating in the Global Market

The report includes a competitive analysis of the market structure, with information on the top companies functioning in the global market. The study highlights some of the leading companies that are projected to expand their market footprint in the coming years. Few of the key players mentioned in the report include EUROIMMUN US, Inc., Creative Diagnostics, Quest Diagnostics, Artron Laboratories Inc., and GenBody Inc.

Buy this report @ https://www.futuremarketinsights.com/checkout/2913

Restraints Hindering the Growth of the Zika Virus POC Testing Market

The major factor limiting revenue growth of the Zika virus POC testing market is the inefficiency of these tests to deliver accurate results. ELISA is said to provide relatively accurate results than the rapid IgG/IgM Zika virus test. Yet companies are unable to deliver products that people can completely rely on, because of the cross-reactivity with other widely circulating virus strands such as Flavivirus, Dengue, Chikungunya and Japanese Encephalitis. Results obtained using Point-of-Care Zika diagnostic test kits are not definitive, thereby affecting revenue generation in the global Zika virus testing market.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you:  https://www.futuremarketinsights.com/askus/rep-gb-2913

More from Healthcare, Pharmaceuticals and Medical devices:

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us

Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44-(0)-20-7692-8790 
Sales: sales@futuremarketinsights.com  
Press OfficePress@futuremarketinsights.com  
Blog: Market Research Blog  
Websitehttps://www.futuremarketinsights.com/

Editor Details

Last Updated: 03-Apr-2020